A Phase I, Open Label, Parallel Group, Three Period, Fixed Sequence Crossover Study to Evaluate the Effect of Dolutegravir on Metformin Pharmacokinetics in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2016
Price : $35 *
At a glance
- Drugs Dolutegravir (Primary) ; Metformin
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 11 Mar 2016 Results published in the JAIDS
- 23 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Apr 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.